Delivery Order SPE2DR25D7067-SPE2DR26FW4BA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,371.44 for M-M-R II vaccine vials, with an ultimate completion date of May 13, 2025. This firm fixed-price contract, awarded on May 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is non-competitive and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,564.63 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of November 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies medications, vaccines, medical devices, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials valued at $9,479.56 with an ultimate completion date of January 6, 2026. This firm fixed-price delivery order, issued on January 5, 2026, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $16,817.04 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is listed as the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.62 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. This contract employs firm fixed price terms with an ultimate completion date of November 25, 2025, and was awarded competitively without a set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $6,759.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of December 23, 2025. This non-set-aside contract was awarded competitively on December 22, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $47,038.50 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub for...
- The Defense Logistics Agency has awarded a delivery order valued at $1,119.10 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,141.87 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of December 18, 2025. This non-competitive delivery order represents a firm fixed price procurement to support federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials valued at $3,856.63 on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DR25D7067Indefinite Delivery Contract
- SPE2DR25D7067-SPE2DR26FW4BADelivery Order
The Defense Logistics Agency awarded a $9,963.87 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 8, 2026, with completion scheduled for January 9, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This primary pharmaceutical supply vehicle enables delivery of a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The M-M-R II vaccine order reflects the company's role in supplying essential immunization products and medical commodities across multiple therapeutic domains. As a major healthcare solutions provider competing on a full and open basis, AmerisourceBergen maintains extensive federal contract experience delivering both brand-name and generic medications, specialty pharmaceuticals, and critical medical supplies to government healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 1/7/26 |